Delic Corp is a Delaware-based psychedelics company that has gone public via RTO.
Exploring the companies and themes that make up this emerging and exciting new sector
Psychedelic Drug Therapy: Cure Your Mind, Save Your Heart?
Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
Numinus plans a "compassionate access" clinical trial of psilocybin to treat substance abuse.
More U.S. Military Funding For Psychedelic Drug R&D As PTSD Crisis Worsens
To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities
Another incremental step forward in one of MindMed's leading psychedelics R&D initiatives.
Mind Cure Announces Non-Brokered Private Placement of up to $3 Million
Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.
A Market Reality Check For Psychedelic Stocks
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.
Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study
The Navy SEAL Foundation (NSF) recently pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study.
Mind Cure Announces Hiring of Award-Winning Experimental Scientist Dr. Ryan Hartwell as Chief Science Officer
Mind Cure's new Chief Science Officer (CSO) brings experience in drug research as well as natural product development.
New Psychedelic Stocks: The Menu Is Getting Longer For Investors
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
Compass joins an international organization dedicated to advancing psychedelic drug research.
Entheon Biomedical Corp. (formerly MPV Exploration Inc.) Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
Entheon Biomedical has announced that it expects to commence public trading on or about November 12th, symbol "ENBI".